Deregulated expression of CDCA3 is associated with solid malignancies including gastric cancer (Yu et al. 2020; Zhang et al. 2019a), liver cancer (Hu et al. 2015), breast cancer (Pérez‐Peña et al. 2017; Phan et al. 2018), oral squamous cell carcinoma tissues (Uchida et al. 2012), non‐small cell lung cancer (Adams et al. 2017), prostate cancer (Chen et al. 2013), and colorectal cancer (Qian et al. 2018; Zhang et al. 2018). The gene discussed is CDCA3; the disease is lung cancer.